Feed SNWV
SN

SANUWAVE Health, Inc.

SNWV · NASDAQ

$4.25 +4.42% (+$0.18)
1M -14.31%
Market Cap $36.5M
P/E Ratio 2.55x
Div. Yield -
ROE 1,728.10%

Bulios Fair Price

$5.18

21.9% upside

Current Price

$4.25

Undervalued Fair Value Overvalued

According to Bulios Fair Price, SNWV is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
4/9
Valuation
89 /100
Cheap
P/E 2.55x
EV/EBITDA 2.48x
P/S 0.83x
Growth
100 /100
Growing
Rev. growth 38.05%
EPS growth N/A
FCF growth N/A
Profitability
67 /100
Strong
Gross margin 75.20%
Net margin 32.60%
Op. margin 1.54%
Quality
64 /100
Average
ROIC 2.80%
ROE 1,728.10%
ROA 39.10%
Debt
54 /100
Moderate
Debt/Equity 7.43x
Current ratio 1.28x
Int. coverage 5.02x
Stability
29 /100
Unstable
Beta 1.50x
Rev. volatility 19.38%
EPS volatility 91.01%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about SNWV
Online

About the company

SANUWAVE Health is an American healthcare company based in Georgia, focused on the development and commercialization of innovative therapeutic devices for tissue regeneration and the treatment of various medical conditions. Founded in 2001, the company is primarily known for its extracellular matrix (ECM) technology, which utilizes pulsatile acoustic energy to accelerate wound healing and improve circulation. SANUWAVE Health targets solutions for treating chronic wounds, orthopedic issues, and other indications, aiming to enhance patients' quality of life.

Sector

Healthcare

Industry

Medical - Devices

CEO

Morgan C. Frank

Employees

55

Headquarters

Eden Prairie

Upcoming events

06 NOV

Earnings

Upcoming earnings report

52d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.